Last Updated: November 9, 2026

CLINICAL TRIALS PROFILE FOR EFLORNITHINE HYDROCHLORIDE

« Back to Dashboard

All Clinical Trials for EFLORNITHINE HYDROCHLORIDE

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003076 ↗	Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus	Completed	National Cancer Institute (NCI)	Phase 2	1995-10-01	RATIONALE: Chemoprevention therapy is the use of drugs to try and prevent the development or recurrence of cancer. It is not known whether eflornithine is effective in preventing cancer in patients with Barrett's esophagus. PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of eflornithine in preventing cancer in patients with Barrett's esophagus.
NCT00003076 ↗	Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus	Completed	University of Michigan Cancer Center	Phase 2	1995-10-01	RATIONALE: Chemoprevention therapy is the use of drugs to try and prevent the development or recurrence of cancer. It is not known whether eflornithine is effective in preventing cancer in patients with Barrett's esophagus. PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of eflornithine in preventing cancer in patients with Barrett's esophagus.
NCT00003076 ↗	Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus	Completed	University of Michigan Rogel Cancer Center	Phase 2	1995-10-01	RATIONALE: Chemoprevention therapy is the use of drugs to try and prevent the development or recurrence of cancer. It is not known whether eflornithine is effective in preventing cancer in patients with Barrett's esophagus. PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of eflornithine in preventing cancer in patients with Barrett's esophagus.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for EFLORNITHINE HYDROCHLORIDE

Condition Name

Chart
Table

Condition Name for EFLORNITHINE HYDROCHLORIDE
Intervention	Trials
Trypanosomiasis, African	5
Neuroblastoma	4
Prostate Cancer	3
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for EFLORNITHINE HYDROCHLORIDE
Intervention	Trials
Trypanosomiasis, African	7
Trypanosomiasis	7
Neuroblastoma	6
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for EFLORNITHINE HYDROCHLORIDE

Trials by Country

Map
Table

Trials by Country for EFLORNITHINE HYDROCHLORIDE
Location	Trials
United States	270
Canada	13
Congo	10
Congo, The Democratic Republic of the	8
Germany	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for EFLORNITHINE HYDROCHLORIDE
Location	Trials
California	13
Texas	13
Florida	11
Minnesota	11
Missouri	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for EFLORNITHINE HYDROCHLORIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for EFLORNITHINE HYDROCHLORIDE
Clinical Trial Phase	Trials
PHASE4	1
PHASE3	1
PHASE2	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for EFLORNITHINE HYDROCHLORIDE
Clinical Trial Phase	Trials
Completed	19
Recruiting	12
Active, not recruiting	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for EFLORNITHINE HYDROCHLORIDE

Sponsor Name

Chart
Table

Sponsor Name for EFLORNITHINE HYDROCHLORIDE
Sponsor	Trials
National Cancer Institute (NCI)	17
Giselle SaulnierSholler	6
Giselle Sholler	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for EFLORNITHINE HYDROCHLORIDE
Sponsor	Trials
Other	73
NIH	17
Industry	16
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.